Mallinckrodt and Questcor Pharmaceuticals on Monday announced that they have entered into a definitive merger agreement under which Mallinckrodt will acquire Questcor in a transaction valued at approximately $5.6 billion.
OncologyRx Care Advantage, McKesson Specialty Health’s oral oncology products specialty pharmacy, on Monday announced that they have assisted under-insured patients in obtaining $40 million in financial assistance by helping them access financial assistance programs.
The National Association of Chain Drug Stores submitted a written statement in lead-up to Monday’s hearing of the U.S. House Committee on Energy and Commerce Subcommittee on Health urging transparency in how federal agencies conduct enforcement activities to help curb prescription drug diversion and abuse.
The National Association of Boards of Pharmacy recommended that pharmacies no longer dispense combination drugs containing more than 325 mg of acetaminophen per dosage unit in light of recent regulatory action.
Medication nonadherence is common, but it may be reduced by lower drug costs and co-payments, as well as increased follow-up care, according to a study published earlier this week in the Annals of Internal Medicine.
Hospital patients who participated in Walgreens' WellTransitions program were 46% less likely to experience an unplanned hospital readmission within 30 days of discharge, according to new company research released Friday.
The CVS Caremark Charitable Trust, a private foundation created by CVS Caremark, has announced the recipients of nearly 70 grants awarded to free and charitable clinics, school-based health centers and community health centers as part of a $5 million commitment to increase access to health care in communities nationwide.
MannKind Corp. on Tuesday announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration voted 13-to-1 to recommend that Afrezza (insulin human [rDNA origin]) inhalation powder be granted marketing approval by the FDA to improve glycemic control in adults with Type 1 diabetes and voted 14-to-0 to recommend that Afrezza be granted marketing approval by the FDA to improve glycemic control in adults with Type 2 diabetes.
AZO Products, a urinary and vaginal health brand for women, announced the launch of AZO Bladder Control with Go-Less. The product serves as a supplement to prescriptions and over-the-counter options and helps optimize normal bladder activity and bladder strength, the company said.
Greer Labs, a developer and provider of allergy immunotherapy products and services, announced that the Food and Drug Administration has approved Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass mixed pollens allergen extract) sublingual allergy immunotherapy tablet.
Access to good and affordable health care is the No. 1 concern of Americans today, trumping national security, national debt, improving the quality of education, gun violence and protecting privacy rights, according to a survey recently conducted for the National Commission on Certification of Physician Assistants.
A daily low dose of aspirin does not appear to prevent subsequent pregnancy loss among women with a history of one or two prior pregnancy losses, according to researchers at the National Institutes of Health.